Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 7441 to 7455 of 8314 results

  1. Pemigatinib for treating myeloid or lymphoid neoplasms with a FGFR1 rearrangement [ID6172]

    Discontinued Reference number: GID-TA11109

  2. Retifanlimab with chemotherapy for untreated PD-L1-positive metastatic non-small-cell lung cancer TSID 12007

    In development Reference number: GID-TA11567 Expected publication date: TBC

  3. Tislelizumab with chemotherapy for untreated advanced oesophageal squamous cell cancer ID5113

    In development Reference number: GID-TA11025 Expected publication date: TBC

  4. Sodium phenylbutyrate–ursodoxicoltaurine for treating amyotrophic lateral sclerosis [ID6246]

    Discontinued Reference number: GID-TA11264

  5. Atopic Dermatitis (Eczema)

    Discontinued Reference number: GID-NG10289

  6. Breathlessness

    Discontinued Reference number: GID-NG10387

  7. Haemochromatosis

    Discontinued Reference number: GID-NG10287

  8. Reducing the mortality and morbidity for healthcare associated infections

    Discontinued Reference number: GID-NG10059

  9. Acute bowel obstruction

    Discontinued Reference number: GID-NG10377

  10. Type 2 diabetes in adults: management - insulin therapy

    Discontinued Reference number: GID-NG10375

  11. Preterm labour and birth - predicting preterm birth

    Discontinued Reference number: GID-NG10384

  12. Preterm labour and birth - timing of cord clamping

    Discontinued Reference number: GID-NG10396

  13. Intrapartum care for healthy women and babies - angle of episiotomy

    Discontinued Reference number: GID-NG10394

  14. Intrapartum care for healthy women and babies - rectal examination after delivery

    Discontinued Reference number: GID-NG10395